FDA Inspection 1010081 — Intrinsic Therapeutics, Inc.

Intrinsic Therapeutics, Inc. — FEI 3006232063

The FDA completed an inspection of Intrinsic Therapeutics, Inc. on March 31, 2017 in Woburn, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 31, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Woburn, MA (United States)

Additional Details

Sponsor, Contract Research Organization